4163 Stock Overview
Primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 4163 from our risk checks.
Al-Dawaa Medical Services Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س82.10 |
| 52 Week High | ر.س121.60 |
| 52 Week Low | ر.س80.90 |
| Beta | 0.058 |
| 11 Month Change | -10.18% |
| 3 Month Change | -11.24% |
| 1 Year Change | -19.19% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.45% |
Recent News & Updates
Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 14
Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price
Sep 24The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing
Jul 29Recent updates
Al-Dawaa Medical Services Company (TADAWUL:4163) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 14Benign Growth For Al-Dawaa Medical Services Company (TADAWUL:4163) Underpins Its Share Price
Sep 24The Returns At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Growing
Jul 29Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)
Jun 03Al-Dawaa Medical Services' (TADAWUL:4163) Strong Earnings Are Of Good Quality
May 08Al-Dawaa Medical Services (TADAWUL:4163) Hasn't Managed To Accelerate Its Returns
Apr 05Al-Dawaa Medical Services (TADAWUL:4163) Has Some Way To Go To Become A Multi-Bagger
Dec 26Al-Dawaa Medical Services (TADAWUL:4163) Has Announced A Dividend Of SAR1.25
Sep 03Return Trends At Al-Dawaa Medical Services (TADAWUL:4163) Aren't Appealing
Jul 13Is Al-Dawaa Medical Services Company (TADAWUL:4163) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 22Returns On Capital Signal Tricky Times Ahead For Al-Dawaa Medical Services (TADAWUL:4163)
Apr 10Some Shareholders Feeling Restless Over Al-Dawaa Medical Services Company's (TADAWUL:4163) P/E Ratio
Mar 14Is Al-Dawaa Medical Services Company (TADAWUL:4163) Trading At A 34% Discount?
Dec 08Shareholder Returns
| 4163 | SA Consumer Retailing | SA Market | |
|---|---|---|---|
| 7D | -5.8% | -3.3% | -1.7% |
| 1Y | -19.2% | -5.0% | -10.5% |
Return vs Industry: 4163 underperformed the SA Consumer Retailing industry which returned -5% over the past year.
Return vs Market: 4163 underperformed the SA Market which returned -10.5% over the past year.
Price Volatility
| 4163 volatility | |
|---|---|
| 4163 Average Weekly Movement | 3.0% |
| Consumer Retailing Industry Average Movement | 3.8% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in SA Market | 7.6% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 4163 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: 4163's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Mohammed Saad Al-Farraj Al-Subaie | www.al-dawaa.com.sa |
Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products.
Al-Dawaa Medical Services Company Fundamentals Summary
| 4163 fundamental statistics | |
|---|---|
| Market cap | ر.س6.98b |
| Earnings (TTM) | ر.س358.65m |
| Revenue (TTM) | ر.س6.19b |
19.5x
P/E Ratio1.1x
P/S RatioIs 4163 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4163 income statement (TTM) | |
|---|---|
| Revenue | ر.س6.19b |
| Cost of Revenue | ر.س3.99b |
| Gross Profit | ر.س2.19b |
| Other Expenses | ر.س1.84b |
| Earnings | ر.س358.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.22 |
| Gross Margin | 35.46% |
| Net Profit Margin | 5.80% |
| Debt/Equity Ratio | 43.8% |
How did 4163 perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yield44%
Payout RatioDoes 4163 pay a reliable dividends?
See 4163 dividend history and benchmarks| Al-Dawaa Medical Services dividend dates | |
|---|---|
| Ex Dividend Date | Nov 12 2024 |
| Dividend Pay Date | Nov 25 2024 |
| Days until Ex dividend | 7 days |
| Days until Dividend pay date | 6 days |
Does 4163 pay a reliable dividends?
See 4163 dividend history and benchmarks